𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

✍ Scribed by George Fountzilas; Anna Fragkoulidi; Anna Kalogera-Fountzila; Martha Nikolaidou; Mattheos Bobos; Julien Calderaro; Felipe Andreiuolo; Marios Marselos

Publisher
Springer
Year
2009
Tongue
English
Weight
639 KB
Volume
65
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of piritrexim in combin
A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer
✍ Everett E. Vokes; Isaiah W. Dimery; Charlotte D. Jacobs; Daniel Karp; Arturo Mol πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 468 KB πŸ‘ 2 views

Thirty patients with recurrent and/or metastatic head and neck cancer were treated with sequentially administered methotrexate (MTX) and piritrexim (PTX). The treatment schedule consisted of intravenous (IV) MTX (50 mg/m') administered on day 1 and oral PTX (75 mg/mz) administered twice daily on day

Phase I/II study of S-1 combined with ca
Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy
✍ Akihito Watanabe; Masanobu Taniguchi; Tetsuro Yamashita; Michihiro Ueda; Tatsuya πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## Abstract ## Background. The aims of this study were to determine the recommended dose (RD) in combination chemotherapy of S‐1 and carboplatin in recurrent and/or metastatic head and neck cancer (phase I) and to examine response rate and toxicities at RD (phase II). ## Methods. S‐1 was given o